VRTX Jun 2023 150.000 put
| Previous close | 1.1000 |
| Open | 1.3000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 150.00 |
| Expiry date | 2023-06-16 |
| Day's range | 1.1000 - 1.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 21 |
- Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Last year's bear market made many victims among even the most prominent corporations although growth stocks fared even worse than other categories of equities. Among this small group of outperformers are two healthcare leaders: biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) and medical device expert DexCom (NASDAQ: DXCM). Let's consider why Vertex Pharmaceuticals and DexCom are excellent stocks to buy.
- Zacks
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Ultragenyx (RARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool
2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade
The healthcare industry has proven to be a remarkably resilient place to put capital to work in a wide range of environments. From life-saving medicines and therapies to vaccines, these are just a few examples of the essential products that healthcare companies make that render them particularly defensive investments in a bearish environment. AbbVie (NYSE: ABBV) is a pharmaceutical giant.
